Concepedia

M Fong

MF

10

Publications

1.7K

Citations

10

H-Index

1991

Active since

Affiliations

Otsuka (United States)(Current)

Otsuka Pharmaceutical (Spain)

National Institutes of Health

M Fong is an author at Otsuka (United States) specializing in medicine, immunology, and autoimmunity.

Top concepts

Publications per year

1991–2007

10

Publications

10

Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

Gideon Strassmann, M Fong, J S Kenney et al. · Journal of Clinical Investigation · 1992 · 650 citations · Full text

, , +19

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

Gideon Strassmann, Vina Patil-koota, F D Finkelman et al. · The Journal of Experimental Medicine · 1994 · 367 citations

, , +20

Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages

Taku Kambayashi, Chaim O. Jacob, Dandan Zhou et al. · The Journal of Immunology · 1995 · 159 citations

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.

Gideon Strassmann, M Fong, Carl E. Freter et al. · Journal of Clinical Investigation · 1993 · 132 citations · Full text

Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF- <i>alpha</i> release via a mechanism involving IL-10.

Taku Kambayashi, H. Richard Alexander, M Fong et al. · The Journal of Immunology · 1995 · 129 citations · Full text

Rows per page

1–5 of 10